Clinical Trials Logo

Tobacco Use clinical trials

View clinical trials related to Tobacco Use.

Filter by:

NCT ID: NCT05118139 Recruiting - Smoking Clinical Trials

CSD201203: A Study to Determine Subject Puffing Patterns of a Non-cylindrical, Closed, Electronic Nicotine Delivery System at Three Nicotine Concentrations in an Ambulatory Setting

Start date: February 11, 2022
Phase: N/A
Study type: Interventional

This is a multi-center, open-label, parallel, three-study-group investigation to evaluate the puffing patterns of healthy adult consumers of tobacco products switching from a usual brand (UB) Electronic Nicotine Delivery Systems (ENDS) product to the ENDS Investigational Product (IP), over a 9-day ambulatory period.

NCT ID: NCT05114863 Completed - Smoking Clinical Trials

CSD200907: A Study to Assess Elements of Abuse Liability for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants

Start date: November 29, 2021
Phase: N/A
Study type: Interventional

This is a single-center, open-label, randomized, 2-arm, within-arm cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics [PD]), and plasma nicotine uptake (pharmacokinetics [PK]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers.

NCT ID: NCT05102786 Completed - Smoking Clinical Trials

CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers

Start date: October 26, 2021
Phase:
Study type: Observational

This is a multi-site, open-label, 8-week, prospective observational study, conducted at multiple sites geographically dispersed within the U.S. The purpose of this Actual Use Study (AUS) is to investigate how U.S. adult tobacco consumers 21 to 60 years of age, inclusive, who typically smoke on average (≥5 cigarettes/day) on at least 20 out of the past 30 days will use a heated tobacco product comprising a heating device and four non-combusted cigarette variants (HTP Investigational Product [IP]) over a 6-week Actual Use Period (AUP) in their real-life/naturalistic environment and in the context of typical consumer marketing materials.

NCT ID: NCT05095779 Completed - Tobacco Use Clinical Trials

Incentives for Smoking Cessation in Persistent Poverty Counties

Start date: March 9, 2022
Phase: N/A
Study type: Interventional

The proposed pilot project is designed to evaluate the feasibility and potential efficacy of offering small financial incentives for the completion of smoking cessation counseling and self-reported abstinence at follow-up among Oklahoma Tobacco Helpline (OTH) callers living in persistent poverty counties (PPCs). The study will enroll at least 160 adults who reside in any of the 16 persistent poverty counties in Oklahoma, who are seeking smoking cessation treatment through the OTH.

NCT ID: NCT05092919 Completed - Tobacco Use Clinical Trials

The Effect of Sweet Flavoring on the Rewarding and Reinforcing Value of Cigarillo Use Among Young Adults

FLAV
Start date: September 14, 2021
Phase: Early Phase 1
Study type: Interventional

This within-subjects study aims to evaluate the subjective rewarding value, the relative reinforcing value, and the absolute reinforcing value of sweet flavored cigarillos across three separate laboratory visits among 86 young adults (ages 18-24 years old) who have previously smoked > 10 or more cigarillos in their lifetime.

NCT ID: NCT05081843 Completed - Adolescent Behavior Clinical Trials

Pittsburgh and Rural Area High School Tobacco Prevention

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

This research project will explore the feasibility and acceptability of a web-based media literacy tobacco prevention program. The project will be conducted with 9th graders in two schools in the Pittsburgh area.

NCT ID: NCT05081154 Completed - Smoking Clinical Trials

CSD201002: Study to Assess Nicotine Uptake From P10 Nicotine Pouches

Start date: October 20, 2021
Phase: N/A
Study type: Interventional

This study is a single-center, open-label, randomized, 7-way crossover study designed to evaluate plasma nicotine pharmacokinetics (PK) parameters following use of the study investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers.

NCT ID: NCT05076708 Active, not recruiting - Smoking Clinical Trials

The Effects of IQOS Use on Cigarette Smoking Behaviors

IQOS
Start date: August 26, 2021
Phase: Early Phase 1
Study type: Interventional

This within-subjects study aims to evaluate the effects of IQOS use on combustible cigarette smoking behaviors among 100 cigarette smokers who completed the study. After measuring baseline cigarette smoking rate, participants will receive an IQOS device and be instructed to use it (versus cigarettes) over a 14-day period. The investigators will also examine which objective and subjective effects of IQOS use predict a complete and incomplete switch from cigarettes to IQOS.

NCT ID: NCT05066126 Completed - Tobacco Use Clinical Trials

Mixed Presentation on Social Media

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

This study is to understand how the presentation of information on social media influences processing and recall of information, particularly in relation to modified risk tobacco products. Participants will see a social media site where either (a) the topic of discussion varies between each post or (b) posts on the same topic are grouped together. They will then be asked to recall information about the posts they saw on the site.

NCT ID: NCT05030194 Completed - Tobacco Use Clinical Trials

Comparing Nicotine Delivery, Subjective Effects, and Sensory Experiences of Tobacco Users Using Oral Nicotine Products and Electronic Cigarettes [ZYN Study]

Start date: October 21, 2021
Phase: N/A
Study type: Interventional

To pilot test the appeal of non-tobacco oral nicotine products in cigarette smokers, smokeless tobacco users, and oral nicotine users.